These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 35401550)

  • 1. Kappa Free Light Chains, Soluble Interleukin-2 Receptor, and Interleukin-6 Help Explore Patients Presenting With Brain White Matter Hyperintensities.
    Levraut M; Landes C; Mondot L; Cohen M; Bresch S; Brglez V; Seitz-Polski B; Lebrun-Frenay C
    Front Immunol; 2022; 13():864133. PubMed ID: 35401550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kappa Free Light Chain Biomarkers Are Efficient for the Diagnosis of Multiple Sclerosis: A Large Multicenter Cohort Study.
    Levraut M; Laurent-Chabalier S; Ayrignac X; Bigaut K; Rival M; Squalli S; Zéphir H; Alberto T; Pekar JD; Ciron J; Biotti D; Puissant-Lubrano B; Camdessanché JP; Tholance Y; Casez O; Toussaint B; Marion J; Moreau T; Lakomy D; Thomasset A; Maillart E; Sterlin D; Maurousset A; Rocher A; Laplaud DA; Bigot-Corbel E; Bertho PO; Pelletier J; Boucraut J; Labauge P; Vincent T; De Sèze J; Jahn I; Seitz-Polski B; Thouvenot E; Lebrun-Frenay C;
    Neurol Neuroimmunol Neuroinflamm; 2023 Jan; 10(1):. PubMed ID: 36376096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of κ free light chains in cerebrospinal fluid as a biomarker in multiple sclerosis diagnosis: development of a diagnosis algorithm.
    Valencia-Vera E; Martinez-Escribano Garcia-Ripoll A; Enguix A; Abalos-Garcia C; Segovia-Cuevas MJ
    Clin Chem Lab Med; 2018 Mar; 56(4):609-613. PubMed ID: 29087953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy of intrathecal kappa free light chains compared with OCBs in MS.
    Duell F; Evertsson B; Al Nimer F; Sandin Å; Olsson D; Olsson T; Khademi M; Hietala MA; Piehl F; Hansson M
    Neurol Neuroimmunol Neuroinflamm; 2020 Jul; 7(4):. PubMed ID: 32527760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrathecal kappa free light chains as markers for multiple sclerosis.
    Vecchio D; Bellomo G; Serino R; Virgilio E; Lamonaca M; Dianzani U; Cantello R; Comi C; Crespi I
    Sci Rep; 2020 Nov; 10(1):20329. PubMed ID: 33230241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CSF Free Light Chains as a Marker of Intrathecal Immunoglobulin Synthesis in Multiple Sclerosis: A Blood-CSF Barrier Related Evaluation in a Large Cohort.
    Senel M; Mojib-Yezdani F; Braisch U; Bachhuber F; Lewerenz J; Ludolph AC; Otto M; Tumani H
    Front Immunol; 2019; 10():641. PubMed ID: 30984199
    [No Abstract]   [Full Text] [Related]  

  • 7. Cerebrospinal fluid immunoglobulin kappa light chain in clinically isolated syndrome and multiple sclerosis.
    Senel M; Tumani H; Lauda F; Presslauer S; Mojib-Yezdani R; Otto M; Brettschneider J
    PLoS One; 2014; 9(4):e88680. PubMed ID: 24695382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Increasing Role of Kappa Free Light Chains in the Diagnosis of Multiple Sclerosis.
    Konen FF; Schwenkenbecher P; Jendretzky KF; Gingele S; Sühs KW; Tumani H; Süße M; Skripuletz T
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of kappa free light chains as a diagnostic biomarker in multiple sclerosis and clinically isolated syndrome: A multicenter study.
    Presslauer S; Milosavljevic D; Huebl W; Aboulenein-Djamshidian F; Krugluger W; Deisenhammer F; Senel M; Tumani H; Hegen H
    Mult Scler; 2016 Apr; 22(4):502-10. PubMed ID: 26199348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kappa free light chain index as a diagnostic biomarker in multiple sclerosis: A real-world investigation.
    Rosenstein I; Rasch S; Axelsson M; Novakova L; Blennow K; Zetterberg H; Lycke J
    J Neurochem; 2021 Nov; 159(3):618-628. PubMed ID: 34478561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Free light chains as a reliable biomarker of intrathecal synthesis in the diagnosis of CNS inflammatory diseases.
    Michetti L; Maffina F; Ravasio R; Barcella V; Radaelli M; Chiudinelli L; Sessa M; Alessio MG
    J Neuroimmunol; 2023 Jun; 379():578091. PubMed ID: 37210840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Levels of Cerebrospinal Fluid Kappa Free Light Chains Relate to IgM Intrathecal Synthesis and Might Have Prognostic Implications in Relapsing Multiple Sclerosis.
    Castillo-Villalba J; Gil-Perotín S; Gasque-Rubio R; Cubas-Nuñez L; Carratalà-Boscà S; Alcalá C; Quintanilla-Bordás C; Pérez-Miralles F; Ferrer C; Cañada Martínez A; Tortosa J; Solís-Tarazona L; Campos L; Leivas A; Laíz Marro B; Casanova B
    Front Immunol; 2022; 13():827738. PubMed ID: 35330910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kappa free light chains in cerebrospinal fluid to identify patients with oligoclonal bands.
    Süße M; Hannich M; Petersmann A; Zylla S; Pietzner M; Nauck M; Dressel A
    Eur J Neurol; 2018 Sep; 25(9):1134-1139. PubMed ID: 29683546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid IL-12p40, CXCL13 and IL-8 as a combinatorial biomarker of active intrathecal inflammation.
    Bielekova B; Komori M; Xu Q; Reich DS; Wu T
    PLoS One; 2012; 7(11):e48370. PubMed ID: 23226202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrathecal immunoglobulin synthesis: The potential value of an adjunct test.
    Emersic A; Anadolli V; Krsnik M; Rot U
    Clin Chim Acta; 2019 Feb; 489():109-116. PubMed ID: 30529605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study.
    Leurs CE; Twaalfhoven H; Lissenberg-Witte BI; van Pesch V; Dujmovic I; Drulovic J; Castellazzi M; Bellini T; Pugliatti M; Kuhle J; Villar LM; Alvarez-Cermeño JC; Alvarez-Lafuente R; Hegen H; Deisenhammer F; Walchhofer LM; Thouvenot E; Comabella M; Montalban X; Vécsei L; Rajda C; Galimberti D; Scarpini E; Altintas A; Rejdak K; Frederiksen JL; Pihl-Jensen G; Jensen P; Khalil M; Voortman MM; Fazekas F; Saiz A; La Puma D; Vercammen M; Vanopdenbosch L; Uitdehaag B; Killestein J; Bridel C; Teunissen C
    Mult Scler; 2020 Jul; 26(8):912-923. PubMed ID: 31066634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of free light chains lambda and kappa in early multiple sclerosis.
    Voortman MM; Stojakovic T; Pirpamer L; Jehna M; Langkammer C; Scharnagl H; Reindl M; Ropele S; Seifert-Held T; Archelos JJ; Fuchs S; Enzinger C; Fazekas F; Khalil M
    Mult Scler; 2017 Oct; 23(11):1496-1505. PubMed ID: 27899552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The contribute of cerebrospinal fluid free light-chain assay in the diagnosis of multiple sclerosis and other neurological diseases in an Italian multicenter study.
    Bernardi G; Biagioli T; Malpassi P; De Michele T; Vecchio D; Repice AM; Lugaresi A; Mirabella M; Torri Clerici V; Crespi I
    Mult Scler; 2022 Aug; 28(9):1364-1372. PubMed ID: 34965771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated levels of kappa free light chains in CSF support the diagnosis of multiple sclerosis.
    Presslauer S; Milosavljevic D; Brücke T; Bayer P; Hübl W
    J Neurol; 2008 Oct; 255(10):1508-14. PubMed ID: 18685917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relevance of KFLC quantification to differentiate clinically isolated syndrome from multiple sclerosis at clinical onset.
    Vasilj M; Kes VB; Vrkic N; Vukasovic I
    Clin Neurol Neurosurg; 2018 Nov; 174():220-229. PubMed ID: 30278299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.